AL
NFL Biosciences S.A.
ALNFL.PA · PAR
0.78 € -1.39% (-0.01 €)
1M -10.25%
Market Cap 11.0M €
P/E Ratio -
Div. Yield -
ROE -
Valuation
0 /100
Expensive P/S 239,671.00x
P/B 11.29x
P/E N/A
Growth
37 /100
Stable Rev. growth 5.66%
Book val. growth 33.28%
EPS growth N/A
Profitability
2 /100
Weak Gross margin 145,963.00%
FCF margin 0.00%
Net margin 4,523,560.00%
Quality
0 /100
Poor ROIC 95.97%
Asset turnover 0.00x
ROA 57.64%
Debt
72 /100
Low Debt/Equity 0.04x
Net debt/EBITDA 0.71x
Current ratio 1.27x
Stability
26 /100
Unstable Beta 1.15x
Profitable years 0
EPS volatility 104.69%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ALNFL.PA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bruno Lafont
Employees
4
Headquarters
Castelnau-le-Lez